Blog

Neoadjuvant treatment with an anthracycline-free regimen in Breast Cancer – Breast International Group

Breast International Group/X

Dec 13, 2024, 15:19

Neoadjuvant treatment with an anthracycline-free regimen in Breast Cancer – Breast International Group

Breast International Group shared a post on X:

“SABCS24.

P3-11-03 poster on results of phase 2 DECRESCENDO study:

Neoadjuvant treatment with an anthracycline-free regimen in patients with HER2-positive, HR-negative, node-negative early breast cancer resulted in a high rate of pCR.”

For more updates, follow OncoDaily.

Anthracycline anthracycline-free Breast Cancer Breast International Group cancer DECRESCENDO study EU4Health HaDEA Jules Bordet Institute neoadjuvant treatment OncoDaily Oncology SABCS24

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Special Coverage